Evidence map›Paper›PMID 27734108›Full record

Trial reportIntensive care medicine2016

Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).

Silvia Calviño Günther, Carole Schwebel, Rebecca Hamidfar-Roy, Agnès Bonadona, Maxime Lugosi, Claire Ara-Somohano, Clémence Minet, Leïla Potton, Jean-Charles Cartier, Aurelien Vésin and 4 more

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04698824 (Hypnose en médecine Interne), which is not on this map. Cited by 28 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 5 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04698824 unknown statusnot on this mapstarted 2021, after this paper: background citation

Hypnose en médecine Interne

TypeobservationalSponsorUniversity Hospital, GrenobleRan2021 to 2021Enrolled70ConditionsHypnosis, Autoimmune Diseases, Medically Unexplained SymptomsArmsHypnosis session
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 5 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Development of a Machine Learning-Based Model for Predicting the Incidence of Peripheral Intravenous Catheter-Associated Phlebitis.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Silvia Calviño GüntherUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France. SCalvino-gunther@chu-grenoble.fr.ORCID http://orcid.org/0000-0003-3586-7205
Carole SchwebelUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Rebecca Hamidfar-RoyUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Agnès BonadonaUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Maxime LugosiUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Claire Ara-SomohanoUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Clémence MinetUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Leïla PottonUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Jean-Charles CartierUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Aurelien VésinAlbert Bonniot Institute, INSERM U823 "Outcome of Cancer and Critical Illness", 38076, Grenoble, France.
Magalie ChautempsUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Lenka StyfalovaUniversity Hospital of Grenoble Alpes, Medical Intensive Care Unit, Albert Michallon Teaching Hospital, CS10217, 38043, Grenoble Cedex 9, France.
Stephane RucklyAlbert Bonniot Institute, INSERM U823 "Outcome of Cancer and Critical Illness", 38076, Grenoble, France.
Jean-François TimsitAlbert Bonniot Institute, INSERM U823 "Outcome of Cancer and Critical Illness", 38076, Grenoble, France.
Centre Hospitalier Universitaire de Grenoble · FRInserm · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe all post-insertion complications involving most used intravascular access, and to determine whether the use of a new-generation transparent dressing (3M™ IV Advanced) might reduce their number and impact on ICU patient outcomes.

methodsPatients older than 18, with an expected length of stay ≥48 h and requiring at least one central venous catheter (CVC), arterial catheter (AC), haemodialysis catheter (HDC), pulmonary arterial catheters (PAC) or peripheral venous catheter (PVC) were randomized into two groups: a new-generation transparent dressing, or the hospital's classical transparent dressing, and were followed daily for any infectious and non-infectious complications. Complications were graduated for severity by an independent international multicentre multidisciplinary panel of practitioners using a Delphi process.

resultsWe included 628 patients, 2214 catheters (873 PVCs, 630 CVCs, 512 ACs and 199 HDCs and PACs) and 4836 dressings. Overall incidence rate was of 60.9/1000 catheter-days. The most common complication was dysfunction (34.6/1000 catheter-days), mainly for PVCs (16/1000 catheter-days) and ACs (12.9/1000 catheter-days). Infectious complications incidence rate in CVCs and ACs was of 14.5/1000, mostly due to colonization (14.2/1000 catheter-days). Thrombosis incidence was of 3.8/1000 catheter-days with severe and very severe complications in 16 cases (1.8/1000 catheter-days) and one thrombosis-related death. 3M™ IV Advanced dressing did not decrease the rate of catheters with at least a minor complication [57.37/1000 vs. 57.52/1000 catheter-days, HR 1.03, CI (0.84-1.27), p = 0.81]. Incidence rates for each single complication remained equivalent: infectious [HR 0.93 (0.62-1.40), p = 0.72], deep thrombosis [HR 0.90 (0.39-2.06), p = 0.80], extravasation and phlebitis [HR 1.40 (0.69-2.82), p = 0.35], accidental removal [1.07 (0.56-2.04), p = 0.84] and dysfunction [HR 1.04 (0.80-1.35), p = 0.79].

conclusionThe ADVANCED study showed the overall risk of complications to intravascular catheters in ICU patients being dysfunction, infection and thrombosis. The 3M™ IV Advanced dressing did not decrease complication rates as compared to standard dressings.

Indexed as

BandagesAdultCatheterization, PeripheralCatheter-Related InfectionsCatheters, IndwellingCentral Venous CathetersDelphi TechniqueEquipment FailureFemaleHumansIncidenceIntensive Care UnitsIntention to Treat AnalysisLength of StayMaleProspective StudiesAdverse eventCatheter-related complicationsDressingICUSafety

Identifiers

PMID27734108
OpenAlexW2531649746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.